Premium
Protein S‐nitrosylation regulates Ca2+ handling and myofilament Ca2+ sensitivity in beta‐adrenergic signaling
Author(s) -
Irie Tomoya,
Sips Patrick,
Tokuda Kentaro,
Ichinose Fumito
Publication year - 2013
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.27.1_supplement.921.5
Subject(s) - phospholamban , ryanodine receptor , medicine , chemistry , nitrosylation , endocrinology , ryanodine receptor 2 , stimulation , myofilament , troponin i , s nitrosylation , receptor , nitric oxide , phosphorylation , cysteine , biology , biochemistry , actin , myocardial infarction , enzyme
Objective To assess the impact of increased rotein denitrosylation on beta‐adrenergic receptor (b‐AR)‐dependent signaling and to evaluate effects of augmented denitrosylation during nitrosative stress in cardiomyocytes. Methods and Results We studied cardiomyocytes isolated from wild‐type (WT) and cardiomyocytespecific S‐nitrosoglutathione reductase (GSNOR) overexpressing transgenic (GSNOR‐CMTg) mice. Stimulation of the b‐AR with isoproterenol (ISO)increased sarcomere shortening in both genotypes, while systolic Ca2+ release and sarcoplasmic Ca2+ load only increased in WT. This effect was correlated with increased myofilament Ca2+ sensitivity in ISO‐treated GSNOR‐CMTg cells. Both genotypes showed similar increases in phosphorylation of phospholamban (PLN) and troponin I after b‐AR stimulation while S‐nitrosylation of PLN and troponin C was only increased in WT. Exposure of ISO‐stimulated WT cells to S‐nitrosocysteine severely depressed contractility and systolic Ca2+ release, associated with sarcoplasmic Ca2+ leak and increased ryanodine receptor (RyR2) S‐nitrosylation. GSNOR overexpression prevented RyR2 S‐nitrosylation and preserved contractile function during nitrosative stress. Conclusion These results suggest that b‐AR‐induced S‐nitrosylation of excitation‐contraction coupling proteins is required for b‐AR‐induced augmentation of cardiomyocyte function.